Article Text
Abstract
The therapeutic misconception has been seen as presenting an ethical problem because failure to distinguish the aims of research participation from those receiving ordinary treatment may seriously undermine the informed consent of research subjects. Hence, most theoretical and empirical work on the problems of the therapeutic misconception has been directed to evaluate whether, and to what degree, this confusion invalidates the consent of subjects. We argue here that this focus on the understanding component of informed consent, while important, might be too narrow to capture the ethical complexity of the therapeutic misconception. We show that concerns about misplaced trust and exploitation of such trust are also relevant, and ought to be taken into account, when considering why the therapeutic misconception matters ethically.
- therapeutic misconception
- trust
- informed consent
Statistics from Altmetric.com
Footnotes
Competing interests: None.
Read the full text or download the PDF:
Other content recommended for you
- Diversity in clinical research: public health and social justice imperatives
- Therapeutic appropriation: a new concept in the ethics of clinical research
- Vulnerability, therapeutic misconception and informed consent: is there a need for special treatment of pregnant women in fetus-regarding clinical trials?
- Voluntariness of consent in paediatric HIV clinical trials: a mixed-methods, cross-sectional study of participants in the CHAPAS-4 and ODYSSEY trials in Uganda
- Unconscious emotional reasoning and the therapeutic misconception
- Streamlining the Clinical Research Enterprise
- Living with Crohn’s disease: an exploratory cross-sectional qualitative study into decision-making and expectations in relation to autologous haematopoietic stem cell treatment (the DECIDES study)
- International requirements for consent in biobank research: qualitative review of research guidelines
- Children in health research: a matter of trust
- Informed consent and participant perceptions of influenza vaccine trials in South Africa